Cellular Origins
UK - CambridgeBiotechnology
Focus: Cellular Origins is a UK-based biotechnology company specializing in automated cell therapy manufacturing, positioned at the intersection of gene therapy and cell therapy production. They operate as a public-stage company focused on manufacturing scalability for advanced therapeutics.
Profile data last refreshed 10h ago · AI intelligence enriched 15h ago
Funding Stage
PUBLIC
Open Jobs
22+7 this month
Growing — net +7 jobs in 30d
8 jobs added vs 1 removed. Steady team buildout.
Should You Work at Cellular Origins?
AI assessmentCellular Origins represents a high-upside bet on manufacturing innovation within cell therapy, suitable for professionals seeking early-stage biotech exposure and technical depth in automation rather than traditional clinical development experience.
Why Work Here
- Access to a high-growth market segment: automated cell therapy manufacturing attracted $1.1B across 34 funding rounds globally, signaling strong investor conviction in this space
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Cellular Origins
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.